Reply: Living donor liver transplantation for people with PSC
Hepatology
.
2023 May 1;77(5):E97-E98.
doi: 10.1097/HEP.0000000000000210.
Epub 2023 Jan 3.
Authors
Lisa M Forman
1
,
Gonzalo Sapisochin
2
,
David N Assis
3
,
Lionel Arrivé
4
,
Annika Bergquist
5
,
Christopher L Bowlus
6
,
Mark Deneau
7
,
Sumera I Ilyas
8
,
Keri E Lunsford
9
,
Mercedes Martinez
10
,
Rachna Shroff
11
,
James H Tabibian
12
Affiliations
1
Univeristy of Colorado, Aurora, Colorado, USA.
2
University of Toronto, Toronto, Ontario, Canada.
3
Yale School of Medicine, New Haven, Connecticut USA.
4
Saint Antoine Hospital Paris, France.
5
Karolinska Institute, Karolinska University Hospital Stockholm, Sweden.
6
University of California Davis Health, Sacramento California, USA.
7
University of Utah, Salt Lake City, Utah, USA.
8
Mayo Clinic College of Medicine and Science Rochester, Minnesota, USA.
9
Rutgers University-New Jersey Medical School Newark, New Jersey, USA.
10
Vagelos College of Physician and Surgeons-Columbia University, New York, New York, USA.
11
University of Arizona, Tuscon, Arizona, USA.
12
David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
PMID:
36732294
DOI:
10.1097/HEP.0000000000000210
No abstract available
Publication types
Letter
Comment
MeSH terms
Cholangitis, Sclerosing*
Humans
Liver Transplantation*
Living Donors
Recurrence